Jeffrey Rade to Time Factors
This is a "connection" page, showing publications Jeffrey Rade has written about Time Factors.
Connection Strength
0.605
-
Kakouros N, Gluckman TJ, Conte JV, Kickler TS, Laws K, Barton BA, Rade JJ. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery. J Am Heart Assoc. 2017 Nov 02; 6(11).
Score: 0.086
-
Kakouros N, Nazarian SM, Stadler PB, Kickler TS, Rade JJ. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. J Am Heart Assoc. 2016 Mar 15; 5(3):e002615.
Score: 0.077
-
McLean RC, Nazarian SM, Gluckman TJ, Schulman SP, Thiemann DR, Shapiro EP, Conte JV, Thompson JB, Shafique I, McNicholas KW, Villines TC, Laws KM, Rade JJ. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery. J Cardiovasc Surg (Torino). 2011 Dec; 52(6):877-85.
Score: 0.057
-
Kapur NK, Bian C, Lin E, Deming CB, Sperry JL, Hansen BS, Kakouros N, Rade JJ. Inhibition of transforming growth factor-? restores endothelial thromboresistance in vein grafts. J Vasc Surg. 2011 Oct; 54(4):1117-1123.e1.
Score: 0.056
-
Gluckman TJ, McLean RC, Schulman SP, Kickler TS, Shapiro EP, Conte JV, McNicholas KW, Segal JB, Rade JJ. Effects of aspirin responsiveness and platelet reactivity on early vein graft thrombosis after coronary artery bypass graft surgery. J Am Coll Cardiol. 2011 Mar 01; 57(9):1069-77.
Score: 0.054
-
Rade JJ, Hogue CW. Do we really need another biomarker to diagnose myocardial infarction after coronary artery bypass graft surgery? Anesth Analg. 2010 Nov; 111(5):1086-7.
Score: 0.053
-
Rade JJ, Hogue CW. Noncardiac surgery for patients with coronary artery stents: timing is everything. Anesthesiology. 2008 Oct; 109(4):573-5.
Score: 0.046
-
Kapur NK, Rade JJ. Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease. Trends Cardiovasc Med. 2008 May; 18(4):133-41.
Score: 0.044
-
Deming CB, Kim AY, Bian CE, Regard JB, Rade JJ. cDNA cloning of rabbit thrombomodulin and characterization of gene expression in cardiovascular tissue. DNA Seq. 2003 Dec; 14(6):399-405.
Score: 0.033
-
Kuliopulos A, Gurbel PA, Rade JJ, Kimmelstiel CD, Turner SE, Bliden KP, Fletcher EK, Cox DH, Covic L. PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study. Arterioscler Thromb Vasc Biol. 2020 12; 40(12):2990-3003.
Score: 0.026
-
Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi MS, Meraj PM, Garberich R, Jaffer FA, Stefanescu Schmidt AC, Dixon SR, Rade JJ, Smith T, Tannenbaum M, Chambers J, Aguirre F, Huang PP, Kumbhani DJ, Koshy T, Feldman DN, Giri J, Kaul P, Thompson C, Khalili H, Maini B, Nayak KR, Cohen MG, Bangalore S, Shah B, Henry TD. Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 08 01; 98(2):217-222.
Score: 0.026
-
Hariri E, Lessard D, Gore J, Rade J, Goldberg R. Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction? Cardiovasc Revasc Med. 2020 02; 21(2):182-188.
Score: 0.024
-
Barringhaus KG, Akhter M, Rade JJ, Smith C, Fisher DZ. Operator and institutional experience reduces room-to-balloon times for transradial primary percutaneous coronary intervention. J Invasive Cardiol. 2014 Feb; 26(2):80-6.
Score: 0.017
-
Grines CL, Watkins MW, Mahmarian JJ, Iskandrian AE, Rade JJ, Marrott P, Pratt C, Kleiman N. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol. 2003 Oct 15; 42(8):1339-47.
Score: 0.008